NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
162 hedge funds and large institutions have $2.19B invested in NEVRO CORP. in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 45 reducing their positions, and 30 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 45
10% more capital invested
Capital invested by funds: $2B → $2.19B (+$191M)
6% less funds holding
Funds holding: 172 → 162 (-10)
23% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 30
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
84% less call options, than puts
Call options by funds: $6.05M | Put options by funds: $36.7M
Top Buyers
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$95.8M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$93.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$91.6M |
| 4 |
HM
HealthCor Management
New York
|
+$60.4M |
| 5 |
PA
Perceptive Advisors
New York
|
+$44.9M |
Top Sellers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$59.5M |
| 2 |
Millennium Management
New York
|
-$57.4M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$45.5M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$17.8M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.5M |
NVRO Hedge Fund Activity: Q2 2019 in Review
162 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2019, worth a combined $2.19B — up 9.5% from $2B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of NVRO and 23 opened new positions — a net loss of 7 holders — while 45 trimmed existing stakes and 63 added.
The largest buyer was Jackson Square Partners, opening a new position worth an estimated $95.8M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $59.5M.
- 162 institutional investors held NEVRO CORP. (NVRO) as of Q2 2019, down from 172 in Q1 2019.
- Funds reported $2.19B of NEVRO CORP. stock for Q2 2019, up 9.5% quarter-over-quarter.
- 23 funds opened new NEVRO CORP. positions in Q2 2019 and 30 closed out, a net change of -7 holders.
- The largest NEVRO CORP. buyer in Q2 2019 was Jackson Square Partners, an estimated $95.8M added.
- The largest NEVRO CORP. seller in Q2 2019 was ArrowMark Colorado Holdings, an estimated $59.5M sold.
Based on aggregated 13F filings for Q2 2019.